For instance, NK-derived exosomes carrying the tumor-suppressive miRNA-186 exhibited cytotoxicity against MYCN-amplified neuroblastoma cells, where miRNA-186 inhibited MYCN and exempted cancer cells from TGFβ1-dependent immune escape (39). The gene discussed is MYCN; the disease is neuroblastoma.